Captopril ( DrugBank: Captopril )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
17	Multiple system atrophy	1
86	Pulmonary arterial hypertension	1

17. Multiple system atrophy

---

Clinical trials : 118 /  Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01292694 (ClinicalTrials.gov)	March 2011	8/2/2011	Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure	Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure	Hypertension;Pure Autonomic Failure;Multiple System Atrophy	Drug: Losartan;Drug: Captopril;Drug: Placebo	Vanderbilt University	NULL	Terminated	18 Years	85 Years	All	12	Phase 1	United States

86. Pulmonary arterial hypertension

---

Clinical trials : 1,181 /  Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00240656 (ClinicalTrials.gov)	October 2005	17/10/2005	Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension	Official Title: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease—Focus on Pulmonary Artery Remodeling	Hypertension, Pulmonary	Drug: spironolactone captopril carvedilol	Hebei Medical University	NULL	Completed	N/A	80 Years	Both		Phase 1	China